This study aimed to compare the performance of immunohistochemistry (IHC)‐based luminal subtyping of breast cancer against gene expression panels at our institute and to evaluate a CE‐certified artificial intelligence (AI) Ki67 image analysis program for improving subtyping accuracy. The gene discussed is MKI67; the disease is breast cancer.